Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Oing

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2021
Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosisChristoph Oing
Current Opinion in Urology|June 30, 2018
Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancerChristoph Oing, Carsten Bokemeyer
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|January 11, 2021
[Increasing combination possibilities for first-line treatment of metastatic clear cell renal cell carcinoma with nivolumab plus cabozantinib]Christoph Oing, Carsten Bokemeyer
Aktuelle Urologie|August 6, 2024
[Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours]Christoph Oing, Marcus Hentrich
Oncology Research and Treatment|May 30, 2018
The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell TumorsChristoph Oing, Anja Lorch
Pathologie (Heidelberg, Germany)|September 26, 2022
[Testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer]Christoph Oing, Christian Daniel Fankhauser
Minerva Urology and Nephrology|December 21, 2023
Genomic tests for persistence PSA after radical prostatectomy: smoke and mirrors or new effective tools for the clinical decision-making?Enrico Checcucci, Christoph Oing, Pasquale Rescigno
Deutsches Arzteblatt International|June 28, 2023
Testicular TumorsSusanne Krege, Christoph Oing, Carsten Bokemeyer
Expert Review of Anticancer Therapy|March 9, 2018
Therapeutic approaches for refractory germ cell cancerChristoph Oing, Christoph Seidel, Carsten Bokemeyer
Der Pathologe|December 2, 2020
[What does the oncologist need from the pathologist in testicular cancer?]Christoph Oing, Mia-Carlotta Peters, Felix Bremmer
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2021
Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosisChristoph Oing
Current Opinion in Urology|June 30, 2018
Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancerChristoph Oing, Carsten Bokemeyer
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|January 11, 2021
[Increasing combination possibilities for first-line treatment of metastatic clear cell renal cell carcinoma with nivolumab plus cabozantinib]Christoph Oing, Carsten Bokemeyer
Aktuelle Urologie|August 6, 2024
[Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours]Christoph Oing, Marcus Hentrich
Oncology Research and Treatment|May 30, 2018
The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell TumorsChristoph Oing, Anja Lorch
Pathologie (Heidelberg, Germany)|September 26, 2022
[Testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer]Christoph Oing, Christian Daniel Fankhauser
Minerva Urology and Nephrology|December 21, 2023
Genomic tests for persistence PSA after radical prostatectomy: smoke and mirrors or new effective tools for the clinical decision-making?Enrico Checcucci, Christoph Oing, Pasquale Rescigno
Deutsches Arzteblatt International|June 28, 2023
Testicular TumorsSusanne Krege, Christoph Oing, Carsten Bokemeyer
Expert Review of Anticancer Therapy|March 9, 2018
Therapeutic approaches for refractory germ cell cancerChristoph Oing, Christoph Seidel, Carsten Bokemeyer
Der Pathologe|December 2, 2020
[What does the oncologist need from the pathologist in testicular cancer?]Christoph Oing, Mia-Carlotta Peters, Felix Bremmer
Pageof 8